Copyright
©The Author(s) 2023.
World J Virol. Jan 25, 2023; 12(1): 1-11
Published online Jan 25, 2023. doi: 10.5501/wjv.v12.i1.1
Published online Jan 25, 2023. doi: 10.5501/wjv.v12.i1.1
Age on date of CD4+ T-lymphocyte test | ||||||
Stage | < 1 yr | 1–5 yr | ≥ 6 yr | |||
Cells/µL | % | Cells/µL | % | Cells/µL | % | |
1 | ≥ 1500 | ≥ 34 | ≥ 1000 | ≥ 30 | ≥ 500 | ≥ 26 |
2 | 750-1499 | 26-33 | 500-999 | 22-29 | 200-499 | 14-25 |
3 | < 750 | < 26 | < 500 | < 22 | < 200 | < 14 |
Clinicalcategory | Symptomatic conditions |
A | Asymptomatic HIV infection, persistent generalized lymphadenopathy, acute (primary) HIV infection complicated by illness, or a history of acute HIV infection. Bacillary angiomatosis |
B | Candida infection, cervical dysplasia, constitutional symptoms, hairy leukoplakia, herpes zoster, unexplained thrombocytopenic purpura, listeriosis, pelvic inflammatory disease, and peripheral neuropathy. |
C | AIDS-defining diseases: Toxoplasmosis, Kaposi's sarcoma, Pneumocystis pneumonia |
- Citation: Salimi M, Mirghaderi P, Mosalamiaghili S, Mohammadi A, Salimi A. Joint replacement and human immunodeficiency virus. World J Virol 2023; 12(1): 1-11
- URL: https://www.wjgnet.com/2220-3249/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.5501/wjv.v12.i1.1